<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Ozempic - Garner Ted Armstrong Evangelistic Association</title>
	<atom:link href="https://www.garnertedarmstrong.org/tag/ozempic/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.garnertedarmstrong.org</link>
	<description>Let No Man Take Your Crown</description>
	<lastBuildDate>Tue, 16 Dec 2025 23:21:15 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.garnertedarmstrong.org/wp-content/uploads/2024/05/cropped-Screen-Shot-2024-05-16-at-1.06.13-PM-32x32.png</url>
	<title>Ozempic - Garner Ted Armstrong Evangelistic Association</title>
	<link>https://www.garnertedarmstrong.org</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs</title>
		<link>https://www.garnertedarmstrong.org/lawsuits-claiming-ozempic-other-glp-1s-led-to-blindness-become-second-mass-litigation-over-the-drugs/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=lawsuits-claiming-ozempic-other-glp-1s-led-to-blindness-become-second-mass-litigation-over-the-drugs</link>
		
		<dc:creator><![CDATA[Diana Novak Jones | Reuters]]></dc:creator>
		<pubDate>Tue, 16 Dec 2025 23:21:15 +0000</pubDate>
				<category><![CDATA[Breaking News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[blindness]]></category>
		<category><![CDATA[GLP-1]]></category>
		<category><![CDATA[Ozempic]]></category>
		<category><![CDATA[Weight Loss Drugs]]></category>
		<guid isPermaLink="false">https://www.garnertedarmstrong.org/?p=48462</guid>

					<description><![CDATA[<p>DEC 15 (Reuters) &#8211; A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly alleging patients lost some or all of their eyesight while taking the companies&#8217; blockbuster weight loss &#8230; <a class="kt-excerpt-readmore" href="https://www.garnertedarmstrong.org/lawsuits-claiming-ozempic-other-glp-1s-led-to-blindness-become-second-mass-litigation-over-the-drugs/" aria-label="Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs">Read More</a></p>
<p>The post <a href="https://www.garnertedarmstrong.org/lawsuits-claiming-ozempic-other-glp-1s-led-to-blindness-become-second-mass-litigation-over-the-drugs/">Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs</a> first appeared on <a href="https://www.garnertedarmstrong.org">Garner Ted Armstrong Evangelistic Association</a>.</p>]]></description>
										<content:encoded><![CDATA[<div class="text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__full_width__kCIGb body-module__small_body__gOmDf article-body-module__paragraph__Ts-yF" data-testid="paragraph-0">DEC 15 (Reuters) &#8211; A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly alleging patients lost some or all of their eyesight while taking the companies&#8217; blockbuster weight loss drugs before a judge in Pennsylvania.</div>
<div data-testid="paragraph-0"></div>
<div class="text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__full_width__kCIGb body-module__small_body__gOmDf article-body-module__paragraph__Ts-yF" data-testid="paragraph-1">The U.S. Judicial Panel on Multidistrict Litigation, which manages complex federal litigation, agreed with the plaintiffs that the cases should be centralized in their own multi-district litigation (MDL) in Philadelphia federal court rather than added to the existing mass litigation in the same court over gastrointestinal side effects of the drugs.</div>
<div data-testid="paragraph-1"></div>
<div data-testid="paragraph-1">
<p>Continue reading <a href="https://www.reuters.com/legal/government/lawsuits-claiming-ozempic-other-glp-1s-led-blindness-become-second-mass-2025-12-15/?fbclid=IwY2xjawOuwm1leHRuA2FlbQIxMQBzcnRjBmFwcF9pZBAyMjIwMzkxNzg4MjAwODkyAAEeRRGz1Z_NqGLoVZdI5aRKcQyxpUNZOOa6ddnlOi_4-iia5DiUgA0dAAReg2g_aem_Vn4r86adpwgOqmGblIgsZQ">HERE</a></p>
<p>Source: https://www.reuters.com/legal/government/lawsuits-claiming-ozempic-other-glp-1s-led-blindness-become-second-mass-2025-12-15/?fbclid=IwY2xjawOuwm1leHRuA2FlbQIxMQBzcnRjBmFwcF9pZBAyMjIwMzkxNzg4MjAwODkyAAEeRRGz1Z_NqGLoVZdI5aRKcQyxpUNZOOa6ddnlOi_4-iia5DiUgA0dAAReg2g_aem_Vn4r86adpwgOqmGblIgsZQ</p>
<hr />
[<a href="https://www.garnertedarmstrong.org/news/disclaimer/">Disclaimer</a>]
</div><p>The post <a href="https://www.garnertedarmstrong.org/lawsuits-claiming-ozempic-other-glp-1s-led-to-blindness-become-second-mass-litigation-over-the-drugs/">Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs</a> first appeared on <a href="https://www.garnertedarmstrong.org">Garner Ted Armstrong Evangelistic Association</a>.</p>]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
